Michel Kazatchkine to focus on improving partnerships, health care infrastructures

Michel Kazatchkine -- France's global ambassador for HIV/AIDS and communicable diseases who on Thursday was selected to be the new executive director of the Global Fund To Fight AIDS, Tuberculosis and Malaria -- has announced that he will aim to improve the organization's partnerships with United Nations organizations and donors, the Boston Globe reports (Donnelly, Boston Globe, 2/9).

The Global Fund on Thursday announced that the organization's board had selected Kazatchkine to replace current Executive Director Richard Feachem, whose contract ends in March (Kaiser Daily HIV/AIDS Report, 2/8).

Kazatchkine said that he wants funding to "have a positive spillover effect in helping fight other diseases. That strengthening can only happen through partnerships."

In addition, Kazatchkine said that he hopes Global Fund grants will help to fight not only HIV/AIDS, TB and malaria but also to improve health care infrastructures in developing countries (Boston Globe, 2/9).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rutgers study sheds light on how bedaquiline fights drug-resistant tuberculosis